Ticker Symbol: ICCC
Immucell Corp.
$9.10 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000811641
Company Profile
ImmuCell Corporation's purpose is to create scientifically proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, providing Immediate Immunity™ to newborn dairy and beef calves, and is in the late stages of developing Re-Tain™, a novel treatment for subclinical mastitis without a milk discard requirement that provides an alternative to traditional antibiotics.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2835
Address: 56 Evergreen Dr
Website: www.immucell.com
CEO: Michael Brigham
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $5.25
Change:
$0.01
(
0.29%)
Days Range: $5.05 - $5.35
Beta: -
52wk. High: $8.60
52wk. Low: $4.26
Ytd. Change -13.81%
50 Day Moving Average: $5.09
200 Day Moving Average: $5.09
Shares Outstanding: 7746864
Valuation
Market Cap: 4.1B
PE Ratio: -6.75
EPS (TTM): -0.778
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A